Friday, September 16, 2016

BRIEF-EMA recommends approval of three new cancer treatments

* Recommends approval of Eli Lilly and Boehringer

Ingelheim's Glyxambi for treatment of type 2 diabetes

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)